Theratechnologies

A chessboard with blocks that read MA
Pharma

Thera juggles multiple suitors, including $255M offer from CDMO

The HIV-focused biopharma received the latest bid from Future Pak for a cool $255 million, while the drugmaker is in negotiations with another suitor.
James Waldron Apr 14, 2025 7:45am
shutdown stop plant shutdown

Theratechnologies' HIV med may run short due to contractor issue

Sep 18, 2024 12:11pm
FDA stop sign

FDA spurns Theratechnologies filing over manufacturing concerns

Jan 24, 2024 9:08am
Champion campaign

Theratechnologies’ ‘Champions’ showcases minority HIV patients

Mar 30, 2023 4:16am
Electromicrograph showing an HIV-infected T cell in blue and yellow

FDA approves Taiwanese firm’s Trogarzo for drug-resistant HIV

Mar 7, 2018 8:55am